Auswirkungen der Gesundheitserziehung auf Wissen, Einstellung und Praxis der Postexpositionsprophylaxe
Auswirkungen von Gesundheitserziehung auf Wissen, Einstellung und Praxis der Postexpositionsprophylaxe bei Gesundheitspersonal am Aswan University Hospital, Ägypten
The goal of this study is to learn whether a short education programme helps healthcare workers know more about post-exposure prophylaxis (PEP). PEP is medicine taken soon after contact with blood or body fluids, to lower the chance of infection. The study takes place at Aswan University Hospital in Egypt.
The main questions it aims to answer are:
Do healthcare workers know more about PEP three months after the programme than before it?
Do their attitudes toward PEP change?
Do their reported actions change, such as hepatitis B vaccination, use of PEP after an exposure, and finishing the prescribed course?
Participants are doctors, nurses, and laboratory and blood bank staff who work with patients or blood samples. They will:
Fill out a questionnaire before the programme.
Attend four 2-hour teaching sessions over two weeks.
Fill out the same questionnaire about three months later.
All participants receive the programme. There is no comparison group. Researchers will compare each person's answers before and after the programme to see what changed.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Design. This is a single-group, before-and-after (quasi-experimental) study. Each participant completes a baseline questionnaire before teaching and a follow-up questionnaire about three months after their group finishes teaching. Coded identifiers link the two questionnaires. The study ran from 30 January 2026 to 30 June 2026.
Setting and participants. The study took place at Aswan University Hospital in southern Upper Egypt. Staff were selected by stratified random sampling from three groups: physicians and clinically active academic staff, nurses, and laboratory and blood bank staff. Workers had to be actively employed in one of these groups, have worked at the hospital for at least six months, and give written informed consent. Non-clinical, housekeeping and auxiliary staff were excluded. In total, 380 workers were selected, and the target was 340 with complete before-and-after data.
Intervention. The programme had four 2-hour sessions over two weeks. Topics were:
Recognising and reporting an exposure.
First aid.
Assessing the source patient and the exposure.
Access to PEP in the hospital.
Hepatitis B vaccination.
HIV PEP timing and duration.
Adherence, counselling and follow-up testing.
The programme also covered the difference between HIV prophylaxis, hepatitis B prevention and hepatitis C follow-up. Teaching used slides, short videos, case scenarios, group discussion and printed materials. Physicians were taught in English, and nurses and laboratory staff in Arabic.
Measures. A questionnaire, adapted from published PEP surveys and available in Arabic and English, was used at both time points.
Primary outcome: change in a five-item knowledge score (0-5), calculated as follow-up score minus baseline score.
Secondary outcomes: change in a seven-item attitude and belief score (0-7), and individual practice indicators. These are self-reported hepatitis B vaccination, PEP use after exposure, time to starting PEP, and completion of the prescribed course.
Analysis. Paired changes are tested with the Wilcoxon signed-rank test for scores and the exact McNemar test for yes/no responses. Confidence intervals are reported for paired differences. The sample size was calculated to estimate a proportion with 5% precision, not to detect a difference between paired groups.
Changes from the original registration. The original record described nine knowledge questions and threshold-based classifications of knowledge, attitude and practice. The final analysis uses a five-item knowledge score, a seven-item attitude total without an overall classification, and individual practice indicators. The dates were updated to the actual start (30 January 2026) and completion (30 June 2026).
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Aswān, Ägypten
- Aswan faculty of Medicine
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- HCWs at the selected departments (physicians, nurses and housekeepers).
- Age >18 years old and below 60 years old in both Genders.
- HCWs which have direct contact with blood and body fluids.
Exclusion Criteria:
- Age<18 years old and above 60 years old.
- Non-medical staff at Aswan university hospital.
- Health care workers which have no contact with blood or body fluids.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Health Care workers
About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months |
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Health Practice Change
Zeitfenster: 3 Months
|
Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP). Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers. Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude. Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items. |
3 Months
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Studienstuhl: Shaimaa Sayed Abdelrheem, M.D, Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Durch Blut übertragene Infektionen
- Infektionen
- Viruserkrankungen
- Erkrankungen des Verdauungssystems
- Leberkrankheiten
- Hepatitis, viral, menschlich
- Übertragbare Krankheiten
- DNA-Virusinfektionen
- Hepadnaviridae-Infektionen
- Hepatitis
- Verhalten
- Therapietreue und Compliance
- Gesundheitsverhalten
- Zuverlässigkeit des Patienten
- Patientenakzeptanz der Gesundheitsversorgung
- Adhärenzinterventionen
- Medikamentenhaftung
- Hepatitis B
- Gesundheitserziehung
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- Post-exposure prophylaxis
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .